Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

Rhea-AI Summary

Palisade Bio, Inc. (Nasdaq: PALI) has announced its participation in the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group The company's CEO, J.D. Finley, and CMO, Dr. Mitch Jones, will engage in a fireside chat on Tuesday, October 15th at 4:30 PM ET.

Palisade Bio is a biopharmaceutical company dedicated to developing novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases. The summit will feature presentations and interactive discussions with CEOs and key management from various healthcare sectors, including biotechnology, diagnostics, medical devices, and healthcare information technology.

Interested parties can attend the virtual event by signing up for M-Vest membership. The summit promises to offer timely and engaging industry panels alongside company presentations.

News Market Reaction – PALI

-7.10%

-7.10% Session move

In the trading session that priced this news, PALI declined 7.10%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

– Live webcast fireside chat on Tuesday, October 15^th at 4:30 PM ET

Carlsbad, CA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that J.D. Finley, Chief Executive Officer and Dr. Mitch Jones, CMO of Palisade Bio will participate in a fireside chat at the 2024 Healthcare Virtual Summit, presented by Maxim Group LLC on Tuesday, October 15, 2024 at 4:30 PM ET.

Maxim Senior Analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management. We also plan to host several topical industry panels that promise to be timely and engaging. To attend, just sign up to become an M-Vest member and stay tuned for more updates.

Click here to reserve your seat

About Palisade Bio 
Palisade Bio is a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com

FAQ

When is Palisade Bio (PALI) participating in the Maxim Healthcare Virtual Summit?

Palisade Bio (PALI) is participating in the Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024, with a fireside chat scheduled for 4:30 PM ET.

Who will represent Palisade Bio (PALI) at the 2024 Maxim Healthcare Virtual Summit?

J.D. Finley, CEO, and Dr. Mitch Jones, CMO, will represent Palisade Bio (PALI) at the 2024 Maxim Healthcare Virtual Summit.

What is the focus of Palisade Bio's (PALI) drug development?

Palisade Bio (PALI) focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.

How can investors attend the 2024 Maxim Healthcare Virtual Summit featuring Palisade Bio (PALI)?

Investors can attend the summit by signing up to become an M-Vest member. Details for reserving a seat are provided in the press release.